Tin tức & Cập nhật
Xem bài viết Dược
Xem

Tralokinumab a promising treatment option in young people with moderate-to-severe AD
Targeting interleukin (IL)-13 with tralokinumab monotherapy helps reduce disease activity in adolescents with moderate-to-severe atopic dermatitis (AD) with a low frequency of conjunctivitis throughout the treatment period, according to data from the phase III ECZTRA 6 trial.

Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
Laser acupuncture, when combined with supplementation with calcium and fluoride-containing vitamin D, appears to increase forearm bone mineral density and reduce wrist pain in postmenopausal women with osteoporosis, according to the results of a randomized controlled trial.

Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
In patients with locally advanced or metastatic urothelial cancer patients receiving atezolizumab treatment, immune-related adverse events (AEs) were associated with improved survival outcomes, according to an analysis of individual participant data from the IMvigor210 and IMvigor211 studies.






